Endocrine-disrupting chemicals and risk of diabetes: an evidence-based review
Lind PM, Lind L
Diabetologia 2018;61:1495-502
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Lind PM, Lind L
Diabetologia 2018;61:1495-502
Leggi
Schernthaner G, Schernthaner-Reiter MH
Diabetologia 2018;61:1503-16
Leggi
Hwangbo Y, Kang D, Kang M, et al.
JAMA Oncol. Pub. online June 7, 2018
Leggi
Zaccardi F, Dhalwani NN, David R. et al.
Diabetologia 2018; 61:1592-602
Leggi
Harris SM, Joyce H, Miller A, et al.
Diabet Med. Pub. online 8 June 2018
Leggi
Mulvaney Shelagh A, Vaala s, Hood Korey K, et al.
Diabetes Technol Ther. Pub. online 8 June 2018
Leggi
Sinclair AJ, Gadsby R, Abdelhafiz AH, et al.
Diabet Med. Pub. online 6 June 2018
Leggi
Weaver KW, Hirsch IB
Diabetes Technology & Therapeutics. Pub. online 6 June 2018.
Leggi
Bowman P, Sulen A, Barbetti F, et al.
The Lancet Diabetes & Endocrinology. Pub. online 4 June 2018.
Leggi
Rana JS, Liu JY, Moffet HH, et al.
American Journal of Cardiology. Pub. online 2 June, 2018.
Leggi